European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.76% to 1,450.21 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by furniture manufacturer Natuzzi (NTZ) and accommodations booking company trivago (TRVG), which advanced 23% and 10%, respectively. They were followed by biopharmaceutical companies DBV Technologies (DBVT) and Cellectis (CLLS), which were up 3.4% and 2.7%, respectively.
The only decliners from continental Europe were petroleum refiner Equinor (EQNR) and consumer goods company Unilever (UL), which were down 0.7% and 0.6%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA) and biotech firm Trinity (TRIB), which shed 10% and 9.4%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and tobacco company British American Tobacco (BTI), which rose 4.9% and 2.6%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Silence Therapeutics (SLN), which dropped 7.2% and 1.8%, respectively. They were followed by biopharmaceutical company Amarin (AMRN) and communications company WPP (WPP), which fell 1.7% and 0.9%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。